Psyence Biomedical Ltd. Made Big Gain

Thu, Sep 18, 2025 at 08:00 PM

Psyence Biomedical Ltd. (PBM:NASDAQ) soared at $5.3, representing a gain of 42.5%. On Thu, Sep 18, 2025, PBM:NASDAQ touched a New 2-Week High of $5.3. The stock appeared on our News Catalysts scanner on Tue, Sep 02, 2025 at 06:39 AM in the 'MISCELLANEOUS' category. From Thu, Sep 04, 2025, the stock recorded 80.00% Up Days and 72.73% Green Days

About Psyence Biomedical Ltd. (PBM:NASDAQ)

Psyence cultivates natural psilocybin mushrooms (Psilocybe Cubensis) at our federally licensed ISO22000 facility in Southern Africa.

Top 10 Gainers:

Brera Holdings PLC (BREA:NASDAQ), 225.49%
Adaptimmune Therapeutics plc (ADAP:NASDAQ), 98.02%
Cardlytics, Inc. (CDLX:NASDAQ), 92.66%
89bio, Inc. (ETNB:NASDAQ), 85.15%
SRAX, Inc. (SRAX:NASDAQ), 75%
Laser Photonics Corporation (LASE:NASDAQ), 68.21%
Aeries Technology, Inc (AERT:NASDAQ), 63.85%
Psyence Biomedical Ltd. (PBM:NASDAQ), 42.47%
Aptevo Therapeutics Inc. (APVO:NASDAQ), 40.43%
Robot Consulting Co. Ltd. (LAWR:NASDAQ), 35.64%